Monday, December 23, 2024
HomeTagsDiabetic

Diabetic

Versanis Presents Data Demonstrating Bimagrumab Treatment Leads to Substantial Fat Mass Loss Coupled with Lean Mass Gain in Diabetic

Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, will share analysis of Phase 2 data from prior studies of lead...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics